Healthcare >> CEO Interviews >> February 14, 2005

Elma Hawkins – Advanced Viral Research Corporation (advr)

ELMA S. HAWKINS, PhD, MBA, was named as CEO of Advanced Viral Research Corp. on February 12, 2004. Dr. Hawkins also serves as a member of the Executive Management Committee for ADVR. Previously, Dr. Hawkins served as Vice Chairman of Antigenics, a biotechnology company which is developing personalized immunotherapeutics and revolutionary treatments for cancers, autoimmune diseases and infections. She has also had prior experience in corporate development and regulatory affairs at Genzyme Corporation and held preclinical and regulatory positions at Warner- Lambert/Parke Davis Pharmaceuticals. Dr. Hawkins brings with her two decades of drug development and management experience which should serve Advanced Viral Research Corp. well in advancing its lead product, AVR118, through clinical trials and toward commercialization. Profile
TWST: Would you give us an introduction to Advanced Viral Research Corp.

Dr. Hawkins: Advanced Viral Research Corp. is a publicly traded

biotechnology company located in Yonkers, New York,